SEC Form 4Coverage since May 22, 2026
$PTHS insider trading
Over the last 12 months, Pelthos Therapeutics insiders reported 1 buy totaling $1000K and 5 sales totaling $64K across SEC Form 4 filings. 67% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- $1000K 1 event
- Sold · 12m
- $64K 5 events
- Events · 12m
- 6 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 67% pre-arranged plans
Side
Price · $PTHS · 12Mvia TradingView
Top insiders · 12m
Friedberg Ezra M—2× · $22K
Davis Todd C—1× · $1000K
Francis Knuettel IICFO, Treas & Secty1× · —
Pauls Matthew—1× · $21K
Greenleaf Peter—1× · $21K
All insider trades
6 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Friedberg Ezra MD | ▼ Sale | 558 | $26.09 | $15K | -0.7% | plan · 2 tranches |
| Jul 2, 2026 | Pauls MatthewD | ▼ Sale | 786 | $26.16 | $21K | -5.2% | plan · 2 tranches |
| Jul 2, 2026 | Greenleaf PeterD | ▼ Sale | 797 | $26.13 | $21K | -3.2% | plan · 2 tranches |
| Jun 15, 2026 | Friedberg Ezra MD | ▼ Sale | 283 | $27.29 | $8K | -0.3% | plan · 2 tranches |
| Jun 11, 2026 | Davis Todd CD | ▲ Buy | 35,948 | $27.82 | $1000K | +90.1% | 2 tranches |
| May 22, 2026 | Francis Knuettel IICFO, Treas & Secty · O | ▽ Sale to issuer | 13,947 | — | — | -41.7% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $PTHS feed.